NDC 0536-1021

Peptic Relief

Peptic Relief

Peptic Relief is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rugby Laboratories. The primary component is Bismuth Subsalicylate.

Product ID0536-1021_119b73d8-0694-4709-8e61-49806f3563ee
NDC0536-1021
Product TypeHuman Otc Drug
Proprietary NamePeptic Relief
Generic NamePeptic Relief
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-02-20
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart335
Labeler NameRugby Laboratories
Substance NameBISMUTH SUBSALICYLATE
Active Ingredient Strength262 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0536-1021-07

30 TABLET in 1 BOTTLE (0536-1021-07)
Marketing Start Date2014-02-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0536-1021-07 [00536102107]

Peptic Relief TABLET
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart335
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2014-02-20

Drug Details

Active Ingredients

IngredientStrength
BISMUTH SUBSALICYLATE262 mg/1

OpenFDA Data

SPL SET ID:713a580e-9ddb-44cd-8989-7411b7fd647c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308761
  • NDC Crossover Matching brand name "Peptic Relief" or generic name "Peptic Relief"

    NDCBrand NameGeneric Name
    0536-1021Peptic ReliefPeptic Relief
    11822-0110Peptic ReliefBISMUTH SUBSALICYLATE
    15127-319Peptic ReliefBismuth Subsalicylate
    21695-639Peptic ReliefPeptic Relief
    24385-337Peptic ReliefMaximum Strength Pepto Bismol
    49580-0024Peptic ReliefMaximum Strength Pepto Bismol
    49580-0110Peptic ReliefPepto Bismol
    68016-016Peptic ReliefBismuth Subsalicylate
    68016-024Peptic ReliefBISMUTH SUBSALICYLATE
    68998-371Peptic ReliefBismuth subsalicylate
    68998-372Peptic ReliefBismuth subsalicylate
    68998-526Peptic Reliefbismuth subsalicylate
    68998-527Peptic ReliefPeptic Relief

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.